Praxis Medical Insights

Est. 2024 • Clinical Guidelines Distilled

Made possible by volunteer editors from the University of Calgary & University of Alberta

Last Updated: 10/8/2025

Adverse Reactions to Mirabegron

Common Adverse Effects

  • The American College of Cardiology notes that hypertension occurs in 7.5-11.3% of patients taking mirabegron, compared to 7.6% of patients taking placebo 1
  • Nasopharyngitis occurs in 3.5-3.9% of patients taking mirabegron, compared to 2.5% of patients taking placebo 1
  • Urinary tract infections occur in 2.9-4.2% of patients taking mirabegron, compared to 1.8% of patients taking placebo 1
  • Headache occurs in 2.1-3.2% of patients taking mirabegron, compared to 3.0% of patients taking placebo 1

Skin and Hypersensitivity Reactions

  • The Journal of Allergy and Clinical Immunology reports that urticaria (hives) is a documented allergic-type reaction to mirabegron 2
  • Leukocytoclastic vasculitis is a documented allergic-type reaction to mirabegron 2
  • Rash and pruritus (itching) are documented allergic-type reactions to mirabegron 2
  • Purpura is a documented allergic-type reaction to mirabegron 2
  • Lip edema is a documented allergic-type reaction to mirabegron 2

Comparison to Other Drug Classes

  • The Journal of Allergy and Clinical Immunology notes that mirabegron has a lower allergic reaction profile compared to certain antibiotics, such as carboplatin and fluoroquinolones 2
  • The National Comprehensive Cancer Network notes that mirabegron has a lower allergic reaction profile compared to certain antibiotics, such as carboplatin 3

REFERENCES

1

Mirabegron Side Effects and Safety Profile [LINK]

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

2

drug allergy: a 2022 practice parameter update. [LINK]

Journal of Allergy and Clinical Immunology, 2022

3

epithelial ovarian cancer. [LINK]

Journal of the National Comprehensive Cancer Network : JNCCN, 2011